Targeted Technology Fund II
Overview
Targeted Technology Fund II is a venture capital firm focused on early-stage investments in companies that advance groundbreaking or disruptive technologies to significantly improve medical practices and patient outcomes. The firm also favors technologies that enhance the efficiency, cost-effectiveness, or functionality of developing and manufacturing life science products. The fund concentrates on sectors such as medical devices, life science tools, biotechnology, diagnostics, and specialty pharmaceuticals. It seeks technologies with the potential for a shorter time and lower cost to market, addressing compelling market needs that offer opportunities for enhanced returns. Targeted Technology Fund II's investment model aligns with the current healthcare and economic environment, favoring innovations that can improve clinical outcomes and patient care while reducing healthcare costs. The firm aims to support companies that are poised to make a significant impact in the healthcare sector through technological advancements.
Investment Focus
- Early-stage healthcare technology companies
- Innovative solutions in medical devices, biotechnology, diagnostics, or pharmaceuticals
- Potential for significant market impact and improved patient outcomes
Portfolio Companies
Get the full list of 54,000+ investors
Targeted Technology Fund II and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Targeted Technology Fund II
What sectors does Targeted Technology Fund II invest in?
Targeted Technology Fund II invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Texas, United States. Targeted Technology Fund II is listed as a venture capital in the ConnectSafely investor database.
What stage does Targeted Technology Fund II invest at?
Targeted Technology Fund II backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 1M - 5M.
Which regions does Targeted Technology Fund II invest in?
Targeted Technology Fund II invests across United States.
What companies has Targeted Technology Fund II invested in?
Targeted Technology Fund II's portfolio includes Aerin Medical, Bluegrass Vascular Technologies, DNAtriX and Xenex.
Last updated · Source: ConnectSafely investor database
